|Titre :||Decision making about anti-TNF therapy: A pilot trial of a shared decision-making intervention (2022)|
|Auteurs :||Ellen A. Lipstein, Auteur ; William B. Brinkman, Auteur ; Yin Zhang, Auteur ; Kevin A. Hommel, Auteur|
|Type de document :||Article : texte imprimé|
|Dans :||Patient Education and Counseling (Vol. 105 issue 5, May 2022)|
|Article en page(s) :||pp. 1075-1081|
We conducted a pre-post pilot trial to determine the feasibility and acceptability of a multi-component intervention (pre-clinic letter, shared decision making cards and follow-up phone call) designed to facilitate SDM in pediatric inflammatory bowel disease (IBD).
We recruited physicians (n = 11) caring for IBD patients and families (n = 36) expected to discuss anti-tumor necrosis treatment. We measured feasibility and acceptability of the intervention, observed SDM, perceived SDM, decision conflict, and regret. Medical records were used to assess clinical outcomes, time to decision and adherence. We compared all outcomes between the usual care and intervention study arms.
Two out of three intervention components were feasible. Visit length increased significantly in the intervention arm. Parents and patients rated the intervention as acceptable, as did most physicians. The intervention was associated with a higher-level of observed SDM. There was no difference perceived SDM, decision conflict, regret or quality of life outcomes between arms. Physician global assessment improved over time in the intervention arm.
This pilot trial provides important guidance for developing a larger scale trial of a modified intervention.
Overall, our intervention shows promise in supporting SDM and engaging both parents and patients in pediatric IBD decisions."
|RESO P.12||RE65682445||Bulletin||RESOdoc||Consultation sur place|